IvexSol: iVexSol Closes $23.8M Series A-3 Financing Deal
The new funding will be used to invest in iVexSol's Intelligent Vector Solutions by advancing process and analytical technologies.
Read full article »
IvexSol is a Massachusetts-based biotechnology company that develops and manufactures technology-driven viral vectors for the healthcare industry.
Read more